AKEBIA THERAPEUTICS INC (AKBA) Stock Earnings & Estimates
USA - NASDAQ:AKBA - US00972D1054 - Common Stock
1.805 USD
+0.14 (+8.08%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 292.5M 38.17% | 194.623M -33.46% | 160.18M -17.70% | 245.69M 53.38% | 320.69M 30.53% | 317.49M -1.00% | 388.8M 22.46% | 446.39M 14.81% | 496.58M 11.24% | 531.28M 6.99% | 551.25M 3.76% | |
| EBITDA YoY % growth | 2.99M 101.41% | -6.848M -329.03% | -8.71M -27.19% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -34.7M 86.09% | -44.475M -28.17% | -46.214M -3.91% | 32.568M 170.47% | 62.26M 91.17% | 57.487M -7.67% | 124.75M 117.01% | 182.64M 46.40% | 266.69M 46.02% | 294.09M 10.27% | 308.51M 4.90% | |
| Operating Margin | -11.86% | -22.85% | -28.85% | 13.26% | 19.41% | 18.11% | 32.09% | 40.91% | 53.71% | 55.35% | 55.97% | |
| EPS YoY % growth | -0.44 74.12% | -0.28 36.36% | -0.33 -17.86% | 0.00 99.23% | 0.17 6,740.00% | 0.26 54.62% | 0.38 44.15% | 0.51 35.14% | 0.70 38.00% | 0.86 21.74% | 1.02 19.05% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 100.00% | 0.01 112.75% | -0.02 -168.00% | 0.02 | 0.08 | 0.13 940.00% |
| Revenue Q2Q % growth | 59.4M 57.02% | 64.047M 37.74% | 61.97M 8.08% | 79.04M 26.52% | 96.171M 63.64% | 117.73M 83.82% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 6.095M 154.40% | 9.341M 174.69% | 5.289M -61.43% | 17.211M 23.03% | 29.302M 380.75% | 44.032M 371.38% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.00 100.00% | -0.02 | 0.02 | 100.00% |
| Q2 2025 Q2Q % growth | 0.00 100.00% | -0.02 | 0.02 | 100.00% |
| Q1 2025 Q2Q % growth | 0.03 133.33% | -0.05 | 0.08 | 165.36% |
| Q4 2024 Q2Q % growth | -0.10 | -0.08 | -0.02 | -22.55% |
| Q3 2024 Q2Q % growth | -0.10 -25.00% | -0.06 | -0.04 | -54.81% |
| Q2 2024 Q2Q % growth | -0.04 33.33% | -0.05 | 0.01 | 26.47% |
| Q1 2024 Q2Q % growth | -0.09 35.71% | -0.08 | -0.01 | -15.08% |
| Q4 2023 Q2Q % growth | 0.00 100.00% | -0.04 | 0.04 | 100.00% |
| Q3 2023 Q2Q % growth | -0.08 71.43% | -0.09 | 0.01 | 7.73% |
| Q2 2023 Q2Q % growth | -0.06 -126.09% | -0.03 | -0.03 | -135.29% |
| Q1 2023 Q2Q % growth | -0.14 60.00% | -0.15 | 0.01 | 8.50% |
| Q4 2022 Q2Q % growth | -0.04 90.00% | -0.19 | 0.15 | 78.99% |
| Q3 2022 Q2Q % growth | -0.28 17.65% | -0.15 | -0.13 | -83.01% |
| Q2 2022 Q2Q % growth | 0.23 145.10% | -0.32 | 0.55 | 171.76% |
| Q1 2022 Q2Q % growth | -0.35 22.22% | -0.29 | -0.06 | -19.01% |
| Q4 2021 Q2Q % growth | -0.40 33.33% | -0.34 | -0.06 | -19.35% |
| Q3 2021 Q2Q % growth | -0.34 19.05% | -0.32 | -0.02 | -5.26% |
| Q2 2021 Q2Q % growth | -0.51 -15.91% | -0.32 | -0.19 | -58.10% |
| Q1 2021 Q2Q % growth | -0.45 4.26% | -0.30 | -0.15 | -50.19% |
| Q4 2020 Q2Q % growth | -0.60 24.05% | -0.41 | -0.19 | -46.53% |
| Q3 2020 Q2Q % growth | -0.42 8.70% | -0.18 | -0.24 | -138.70% |
| Q2 2020 Q2Q % growth | -0.44 10.20% | -0.51 | 0.07 | 13.29% |
| Q1 2020 Q2Q % growth | -0.47 24.19% | -0.63 | 0.16 | 25.53% |
| Q4 2019 Q2Q % growth | -0.79 | -0.48 | -0.31 | -63.92% |
| Q3 2019 Q2Q % growth | -0.46 | -0.43 | -0.03 | -5.94% |
| Q2 2019 Q2Q % growth | -0.49 | -0.33 | -0.16 | -49.54% |
| Q1 2019 Q2Q % growth | -0.62 | -0.41 | -0.21 | -51.82% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 58.77M 57.02% | 59.4M | -630K | -1.06% |
| Q2 2025 Q2Q % growth | 62.472M 43.13% | 48.182M | 14.29M | 29.66% |
| Q1 2025 Q2Q % growth | 57.336M 75.84% | 45.78M | 11.556M | 25.24% |
| Q4 2024 Q2Q % growth | 46.497M -17.26% | 38.096M | 8.401M | 22.05% |
| Q3 2024 Q2Q % growth | 37.428M -10.98% | 45.397M | -7.969M | -17.55% |
| Q2 2024 Q2Q % growth | 43.648M -22.58% | 50.439M | -6.791M | -13.46% |
| Q1 2024 Q2Q % growth | 32.607M -18.74% | 47.008M | -14.401M | -30.64% |
| Q4 2023 Q2Q % growth | 56.196M 1.99% | 56.501M | -305K | -0.54% |
| Q3 2023 Q2Q % growth | 42.046M -13.66% | 49.147M | -7.101M | -14.45% |
| Q2 2023 Q2Q % growth | 56.376M -55.40% | 60.282M | -3.906M | -6.48% |
| Q1 2023 Q2Q % growth | 40.127M -34.86% | 47.618M | -7.491M | -15.73% |
| Q4 2022 Q2Q % growth | 55.1M -4.51% | 48.347M | 6.753M | 13.97% |
| Q3 2022 Q2Q % growth | 48.7M -0.20% | 48.111M | 589K | 1.22% |
| Q2 2022 Q2Q % growth | 126.4M 138.94% | 50.725M | 75.675M | 149.19% |
| Q1 2022 Q2Q % growth | 61.6M 17.78% | 45.108M | 16.492M | 36.56% |
| Q4 2021 Q2Q % growth | 57.7M 3.04% | 51.819M | 5.881M | 11.35% |
| Q3 2021 Q2Q % growth | 48.8M -18.67% | 50.663M | -1.863M | -3.68% |
| Q2 2021 Q2Q % growth | 52.9M -41.29% | 53.925M | -1.025M | -1.90% |
| Q1 2021 Q2Q % growth | 52.3M -40.90% | 56.832M | -4.532M | -7.97% |
| Q4 2020 Q2Q % growth | 56M -19.54% | 52.181M | 3.819M | 7.32% |
| Q3 2020 Q2Q % growth | 60M -34.78% | 86.594M | -26.594M | -30.71% |
| Q2 2020 Q2Q % growth | 90.1M -10.62% | 75.668M | 14.432M | 19.07% |
| Q1 2020 Q2Q % growth | 88.5M 21.73% | 79.031M | 9.469M | 11.98% |
| Q4 2019 Q2Q % growth | 69.6M | 95.01M | -25.41M | -26.74% |
| Q3 2019 Q2Q % growth | 92M | 101.37M | -9.37M | -9.24% |
| Q2 2019 Q2Q % growth | 100.8M | 92.949M | 7.851M | 8.45% |
| Q1 2019 Q2Q % growth | 72.7M | 82.636M | -9.936M | -12.02% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 37.5% | 45.31% | 88.64% | 96.09% |
| Revenue | 11.86% | 24.87% | 6.58% | 19.88% |